Stocks News

LAST PRICE
121.6100
TODAY'S CHANGE (%)
Trending Up1.1900 (0.9882%)

Bid / Lots
119.0000/ 5
Ask / Lots
121.0000/ 3
Open / Previous Close
120.5000 / 120.4200
Day Range
Low 116.3200
High 121.9599
52 Week Range
Low 75.8500
High 173.2500
Volume
1,484,714
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 7, 2024
- DJ Sarepta Therapeutics Is Maintained at Buy by Guggenheim, from 2:36PM ET on Thursday Nov 07, 2024 by Dow Jones
  2:36PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 14:36 ET (19:36 GMT)
- DJ Sarepta Therapeutics Is Maintained at Outperform by Baird, from 12:56PM ET on Thursday Nov 07, 2024 by Dow Jones
  12:56PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 12:56 ET (17:56 GMT)
- DJ Sarepta Therapeutics Is Maintained at Outperform by Evercore ISI Group, from 9:18AM ET on Thursday Nov 07, 2024 by Dow Jones
  9:18AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 09:18 ET (14:18 GMT)
- Cantor Fitzgerald Upgrades Sarepta Therapeutics to Overweight, $167 Price Target, from 8:16AM ET on Thursday Nov 07, 2024 by MT Newswires
  8:16AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: SRPT
  08:16 AM EST, 11/07/2024 (MT Newswires) -- Sarepta Therapeutics (SRPT) has an average rating of Buy and price targets ranging from $147.12 to $219, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic resea...
- DJ Sarepta Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald, from 6:58AM ET on Thursday Nov 07, 2024 by Dow Jones
  6:58AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 06:58 ET (11:58 GMT)

Today
- MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm, from 30 minutes ago by Dow Jones
  30 minutes ago by Dow Jones
  Companies Mentioned: MEDP
- MEDP Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Newsfile
  3 hours ago by Newsfile
  Companies Mentioned: MEDP
- MEDP Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: MEDP
- The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medpace Holdings Inc For Securities Law Violations, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: MEDP
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP, from 5 hours ago by PR Newswire
  5 hours ago by PR Newswire
  Companies Mentioned: MEDP
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: MEDP
- Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out, from 6 hours ago by Dow Jones
  6 hours ago by Dow Jones
  Companies Mentioned: MEDP
Yesterday
- Medpace Holdings, Inc. May Have Defrauded Investors And Those With Losses Can Help The Schall Law Firm Investigate, from 12:01PM ET on Saturday Nov 09, 2024 by Dow Jones
  12:01PM ET on Saturday Nov 09, 2024 by Dow Jones
  Companies Mentioned: MEDP
- MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 11:00AM ET on Saturday Nov 09, 2024 by PR Newswire
  11:00AM ET on Saturday Nov 09, 2024 by PR Newswire
  Companies Mentioned: MEDP
- MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 11:00AM ET on Saturday Nov 09, 2024 by Dow Jones
  11:00AM ET on Saturday Nov 09, 2024 by Dow Jones
  Companies Mentioned: MEDP

Sarepta Therapeutics Inc
NASDAQ:SRPTUnited States

Search Criteria

Nov 7, 2024

DJ Sarepta Therapeutics Is Maintained at Buy by Guggenheim, from 2:36PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Sarepta Therapeutics Is Maintained at Outperform by Baird, from 12:56PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Sarepta Therapeutics Is Maintained at Outperform by Evercore ISI Group, from 9:18AM ET on Thursday Nov 07, 2024 by Dow Jones

Cantor Fitzgerald Upgrades Sarepta Therapeutics to Overweight, $167 Price Target, from 8:16AM ET on Thursday Nov 07, 2024 by MT Newswires

DJ Sarepta Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald, from 6:58AM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Today

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm, from 30 minutes ago by Dow Jones

MEDP Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Newsfile

MEDP Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Dow Jones

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medpace Holdings Inc For Securities Law Violations, from 5 hours ago by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP, from 5 hours ago by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP, from 5 hours ago by Dow Jones

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out, from 6 hours ago by Dow Jones

Yesterday

Medpace Holdings, Inc. May Have Defrauded Investors And Those With Losses Can Help The Schall Law Firm Investigate, from 12:01PM ET on Saturday Nov 09, 2024 by Dow Jones

MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 11:00AM ET on Saturday Nov 09, 2024 by PR Newswire

MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 11:00AM ET on Saturday Nov 09, 2024 by Dow Jones